unknown
Stage
1
Investors
About
Freespira develops an FDA-cleared, medication-free digital therapeutic that delivers a 28-day treatment shown to reduce or eliminate symptoms of panic disorder, panic attacks, and post-traumatic stress disorder. Its solution is used by health plans, providers, and self-insured employers to support mental health care and resource utilization.
Explore Freespira's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.